An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

428

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Generalized Anxiety

Interventions

DRUG

Saredutant

oral administration (capsules)

DRUG

Placebo

oral administration (capsules)

Trial Locations (2)

Sanofi-Aventis Administrative Office, Bridgewater

Sanofi-Aventis Administrative Office, Macquarie Park